The phototherapy equipment market is projected to reach USD 0.62 billion by 2031 from USD 0.47 billion in 2026, growing at a CAGR of 5.5%. Neonatal jaundice remains one of the most prevalent conditions among newborns, affecting a significant proportion of both full-term and preterm infants globally. The condition arises due to elevated bilirubin levels, which, if untreated, can lead to severe neurological complications such as kernicterus. Phototherapy is the primary and most widely adopted treatment for managing neonatal jaundice, as it effectively converts bilirubin into water-soluble forms that can be excreted by the infant’s body. The increasing number of births globally, coupled with improved diagnosis rates in hospitals and neonatal intensive care units (NICUs), is contributing to sustained demand for phototherapy equipment. Additionally, healthcare providers are increasingly prioritizing early intervention protocols, which further accelerate device utilization. As a result, hospitals and maternity centers continue to invest in advanced phototherapy systems, including LED-based units, to ensure efficient and safe treatment outcomes. This consistent clinical need makes neonatal jaundice a foundational driver for the long-term growth of the phototherapy equipment market.
This report segments the phototherapy equipment market by product, application, end user, and region.
Prominent players in this market Drägerwerk AG & Co. KGaA (Germany), GE HealthCare (US), Natus Medical (US), Atom Medical (Japan), Bistos (South Korea), Ningbo David (China), Phothera (US), STRATA Skin Sciences (US), Xuzhou Kernel Medical (China), Shanghai SIGMA High-tech (China), Ultralite Enterprises, Inc. (US), Hoenle Medical GmbH (Germany), Weyer (Germany), Neolight (US), Fanem (Brazil), Phoenix Medical Systems (India), Shenzhen Comen Medical Instruments Co. Ltd. (China), Theralight, Inc. (US), UV Technologies (UK), Curelight (Sweden), Photo Therapeutics Ltd (UK), Tiny Hearts Technology (Nigeria), Lifetrons Inno Equipments Pvt Ltd (India), Ibis Medical Equipment and Systems Pvt Ltd (India), Sci Health (Lithuania).
To know about the assumptions considered for the study download the pdf brochure
GE HealthCare (US)
GE HealthCare’s position in the phototherapy equipment market is driven by its comprehensive neonatal care portfolio and advanced LED-based phototherapy systems. The company provides high-quality solutions, such as blanket and overhead phototherapy units used to treat neonatal jaundice, which are widely adopted in hospitals and neonatal intensive care units. It also benefits from a strong global presence and an extensive distribution network, serving healthcare providers in both developed and emerging markets. Its client base includes hospitals, clinics, and neonatal care centers, reinforcing its reputation as a leading provider of innovative and reliable neonatal care technologies.
Drägerwerk AG & Co. KGaA (Germany)
Dräger’s position in the phototherapy equipment market is driven by its advanced portfolio of neonatal care and hospital technology. The company provides high-quality phototherapy systems primarily used for treating neonatal jaundice, widely adopted in hospitals and neonatal intensive care units. Dräger also benefits from a broad international presence, serving customers in more than 190 countries. Its client base includes hospitals, healthcare providers, and neonatal care centers, reinforcing its reputation as a global leader in life-saving medical and neonatal care technologies.
Natus Medical (US)
Natus Medical’s position in the phototherapy equipment market is supported by its specialized focus on newborn care and advanced phototherapy solutions. The company provides LED-based phototherapy systems, including portable and blanket devices, designed for effective treatment of neonatal jaundice across hospital and home care settings. It also benefits from a strong global presence and established relationships with neonatal care providers. Its client base includes hospitals, neonatal intensive care units, and pediatric clinics, reinforcing its reputation as a key player in innovative and patient-centered neonatal care technologies.
Market Ranking
The phototherapy equipment market is competitive, with prominent players accounting for over 46% of the total market share in 2025. Some players dominating the market include Drägerwerk AG & Co. KGaA (Germany), GE HealthCare (US), Natus Medical (US), Phothera (US), and Shanghai SIGMA High-tech (China).
The phototherapy equipment market is characterized by growing opportunities driven by rising demand for non-invasive treatment solutions and expanding healthcare infrastructure across regions such as the Asia Pacific and North America. Market players in countries including China, India, and South Korea are expanding their presence through cost-effective devices and localized manufacturing capabilities. Market participants are focusing on improving device efficiency, portability, connectivity, and regulatory compliance to meet evolving healthcare needs. In recent years, rising awareness of neonatal care, growing preference for home-based treatment, and increasing healthcare investments have significantly boosted market demand. Additionally, technological advancements such as LED-based phototherapy systems, portable devices, and integration with digital monitoring platforms are encouraging companies to enhance product innovation and strengthen their competitive positioning in the global market.
Related Reports:
Phototherapy Equipment Market by Product (Conventional Phototherapy Equipment, Fiber-Optic Phototherapy Equipment), Application (Neonatal Jaundice, Skin Diseases (Psoriasis, Vitiligo)), End User (Hospitals, Homecare Settings) - Global Forecast to 2031
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE